There are 4 papers on Hepatic transaminases in aging research: 2 trials and 1 observational study in people, 1 review.
4 papers study it2 more mention it2 findings
1 new paper in 30 daysSee all 6
- Human trial2
- Humans1
Interventions
2Statins
no changein humans1
1 study
Statins
no changein humans1
Statins were not clearly linked with Hepatic transaminases in humans (P > 0.05; creatine kinase also unchanged).
“without elevating hepatic transaminases or creatine kinase (P > 0.05)”
Humansstandard-dosestandard dose
Frontiers in cardiovascular medicine
Acarbose
upin humans1
1 study
Acarbose
upin humans1
Acarbose increases Hepatic transaminases in humans (alone or in combination with tolbutamide) (3 patients in acarbose group; 2 in acarbose-plus-tolbutamide group).
“Clinically significant elevations in hepatic transaminase levels occurred in 3 patients in the acarbose group and 2 in the acarbose-plus-tolbutamide group.”
Human trialalone or in combination with tolbutamideliver
The American journal of medicine
Latest
3 papers in 12 monthsESC Congress 2026 Abstract
Efficacy and safety of SYH2053 in patients with primary hypercholesterolemia or mixed dyslipidemia: a phase II, multicenter, randomized, double-blind, placebo- and active-controlled trial
Randomized trial in 156 peopleInterventions
International Journal of Nutrology
Major cardiovascular, metabolic, and hypertension outcomes of coenzyme Q10 supplementation in elderly patients: a systematic review and meta-analysis
Meta-analysisCoenzyme Q10
Frontiers in Cardiovascular Medicine
Analysis of the association between SLCO1B1 gene polymorphisms and coronary heart disease risk in southern Han Chinese population and statin responses in the elderly
Cohort study of 6,146 peopleStatins
The American Journal of Medicine
Multicenter, placebo-controlled trial comparing acarbose (BAY g 5421) with placebo, tolbutamide, and tolbutamide-plus-acarbose in non-insulin-dependent diabetes mellitus
Randomized trial in 290 peopleType 2 diabetes